These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26732683)

  • 1. Pharmacokinetics of mefloquine and its effect on sulfamethoxazole and trimethoprim steady-state blood levels in intermittent preventive treatment (IPTp) of pregnant HIV-infected women in Kenya.
    Green M; Otieno K; Katana A; Slutsker L; Kariuki S; Ouma P; González R; Menendez C; ter Kuile F; Desai M
    Malar J; 2016 Jan; 15():7. PubMed ID: 26732683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial.
    González R; Desai M; Macete E; Ouma P; Kakolwa MA; Abdulla S; Aponte JJ; Bulo H; Kabanywanyi AM; Katana A; Maculuve S; Mayor A; Nhacolo A; Otieno K; Pahlavan G; Rupérez M; Sevene E; Slutsker L; Vala A; Williamsom J; Menéndez C
    PLoS Med; 2014 Sep; 11(9):e1001735. PubMed ID: 25247995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnant women with HIV from Gabon and Mozambique: a randomised, double-blind, placebo-controlled trial.
    González R; Nhampossa T; Mombo-Ngoma G; Mischlinger J; Esen M; Tchouatieu AM; Mendes A; Figueroa-Romero A; Zoleko-Manego R; Lell B; Lagler H; Stoeger L; Dimessa LB; El Gaaloul M; Sanz S; Méndez S; Piqueras M; Sevene E; Ramharter M; Saúte F; Menendez C;
    Lancet Infect Dis; 2024 May; 24(5):476-487. PubMed ID: 38224706
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights Into Circulating Cytokine Dynamics During Pregnancy in HIV-Infected Beninese Exposed to Plasmodium falciparum Malaria.
    Ibitokou SA; Denoeud-Ndam L; Ezinmegnon S; Ladékpo R; Zannou DM; Massougbodji A; Girard PM; Cot M; Luty AJ; Ndam NT
    Am J Trop Med Hyg; 2015 Aug; 93(2):287-92. PubMed ID: 26101276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized trial of 2-dose versus monthly sulfadoxine-pyrimethamine intermittent preventive treatment for malaria in HIV-positive and HIV-negative pregnant women in Malawi.
    Filler SJ; Kazembe P; Thigpen M; Macheso A; Parise ME; Newman RD; Steketee RW; Hamel M
    J Infect Dis; 2006 Aug; 194(3):286-93. PubMed ID: 16826475
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cotrimoxazole prophylaxis versus mefloquine intermittent preventive treatment to prevent malaria in HIV-infected pregnant women: two randomized controlled trials.
    Denoeud-Ndam L; Zannou DM; Fourcade C; Taron-Brocard C; Porcher R; Atadokpede F; Komongui DG; Dossou-Gbete L; Afangnihoun A; Ndam NT; Girard PM; Cot M
    J Acquir Immune Defic Syndr; 2014 Feb; 65(2):198-206. PubMed ID: 24220287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.
    Ramharter M; Schwab M; Mombo-Ngoma G; Zoleko Manego R; Akerey-Diop D; Basra A; Mackanga JR; Würbel H; Wojtyniak JG; Gonzalez R; Hofmann U; Geditz M; Matsiegui PB; Kremsner PG; Menendez C; Kerb R; Lehr T
    Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30455233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of sulfadoxine-pyrimethamine in HIV-infected and uninfected pregnant women in Western Kenya.
    Green MD; van Eijk AM; van Ter Kuile FO; Ayisi JG; Parise ME; Kager PA; Nahlen BL; Steketee R; Nettey H
    J Infect Dis; 2007 Nov; 196(9):1403-8. PubMed ID: 17922406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy.
    Haaland RE; Otieno K; Martin A; Katana A; Dinh C; Slutsker L; Menendez C; Gonzalez R; Williamson J; Heneine W; Desai M
    AIDS Res Hum Retroviruses; 2018 Nov; 34(11):912-915. PubMed ID: 30173559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of intermittent preventive treatment of malaria against group B Streptococcus colonization in pregnant women: a nested analysis of a randomized controlled clinical trial of sulfadoxine/pyrimethamine versus mefloquine.
    Capan-Melser M; Mombo Ngoma G; Akerey-Diop D; Basra A; Würbel H; Groger M; Mackanga JR; Zoleko-Manego R; Schipulle U; Schwing J; Lötsch F; Rehman K; Matsiegui PB; Agnandji ST; Adegnika AA; Bélard S; González R; Kremsner PG; Menendez C; Ramharter M
    J Antimicrob Chemother; 2015; 70(6):1898-902. PubMed ID: 25722300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cotrimoxazole versus sulfadoxine-pyrimethamine for intermittent preventive treatment of malaria in HIV-infected pregnant women in Bangui, Central African Republic: A pragmatic randomised controlled trial.
    Manirakiza A; Tondeur L; Ketta MYB; Sepou A; Serdouma E; Gondje S; Bata GGB; Boulay A; Moyen JM; Sakanga O; Le-Fouler L; Kazanji M; Briand V; Lombart JP; Vray M
    Trop Med Int Health; 2021 Oct; 26(10):1314-1323. PubMed ID: 34407273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Challenges in the concurrent management of malaria and HIV in pregnancy in sub-Saharan Africa.
    Brentlinger PE; Behrens CB; Micek MA
    Lancet Infect Dis; 2006 Feb; 6(2):100-11. PubMed ID: 16439330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women.
    Hamer DH; Mwanakasale V; Macleod WB; Chalwe V; Mukwamataba D; Champo D; Mwananyanda L; Chilengi R; Mubikayi L; Mulele CK; Mulenga M; Thea DM; Gill CJ
    J Infect Dis; 2007 Dec; 196(11):1585-94. PubMed ID: 18008241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermittent preventive treatment of malaria in pregnancy: at the crossroads of public health policy.
    Chico RM; Chandramohan D
    Trop Med Int Health; 2011 Jul; 16(7):774-85. PubMed ID: 21477099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of mefloquine intermittent preventive treatment in pregnancy against Schistosoma haematobium infection in Gabon: a nested randomized controlled assessor-blinded clinical trial.
    Basra A; Mombo-Ngoma G; Melser MC; Diop DA; Würbel H; Mackanga JR; Fürstenau M; Zoleko RM; Adegnika AA; Gonzalez R; Menendez C; Kremsner PG; Ramharter M
    Clin Infect Dis; 2013 Mar; 56(6):e68-75. PubMed ID: 23175561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effectiveness of co-trimoxazole to prevent Plasmodium falciparum malaria in HIV-positive pregnant women in sub-Saharan Africa: an open-label, randomized controlled trial.
    Klement E; Pitché P; Kendjo E; Singo A; D'Almeida S; Akouete F; Akpaloo Y; Tossa K; Prince-Agbodjan S; Patassi A; Caumes E
    Clin Infect Dis; 2014 Mar; 58(5):651-9. PubMed ID: 24336820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intermittent Preventive Treatment With Dihydroartemisinin-Piperaquine for the Prevention of Malaria Among HIV-Infected Pregnant Women.
    Natureeba P; Kakuru A; Muhindo M; Ochieng T; Ategeka J; Koss CA; Plenty A; Charlebois ED; Clark TD; Nzarubara B; Nakalembe M; Cohan D; Rizzuto G; Muehlenbachs A; Ruel T; Jagannathan P; Havlir DV; Kamya MR; Dorsey G
    J Infect Dis; 2017 Jul; 216(1):29-35. PubMed ID: 28329368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent treatment for the prevention of malaria during pregnancy in Benin: a randomized, open-label equivalence trial comparing sulfadoxine-pyrimethamine with mefloquine.
    Briand V; Bottero J; Noël H; Masse V; Cordel H; Guerra J; Kossou H; Fayomi B; Ayemonna P; Fievet N; Massougbodji A; Cot M
    J Infect Dis; 2009 Sep; 200(6):991-1001. PubMed ID: 19656069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Population pharmacokinetics of mefloquine in military personnel for prophylaxis against malaria infection during field deployment.
    Charles BG; Blomgren A; Nasveld PE; Kitchener SJ; Jensen A; Gregory RM; Robertson B; Harris IE; Reid MP; Edstein MD
    Eur J Clin Pharmacol; 2007 Mar; 63(3):271-8. PubMed ID: 17216435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.